

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.15549297 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.15549297 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.15549297 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.15549297 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.15549297 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.15549297 |
| 7 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.33692929 |
| 8 | response to peptidoglycan (GO:0032494) | 5.12508556 |
| 9 | protein maturation by protein folding (GO:0022417) | 5.09396550 |
| 10 | hemidesmosome assembly (GO:0031581) | 4.71689102 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.66322832 |
| 12 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.55806136 |
| 13 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.46944320 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.25697413 |
| 15 | positive regulation of heat generation (GO:0031652) | 4.21347819 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 4.13726695 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 4.13726695 |
| 18 | eosinophil chemotaxis (GO:0048245) | 4.11135713 |
| 19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.98417684 |
| 20 | eosinophil migration (GO:0072677) | 3.94009596 |
| 21 | establishment of integrated proviral latency (GO:0075713) | 3.90790013 |
| 22 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.87449081 |
| 23 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.86373774 |
| 24 | respiratory burst (GO:0045730) | 3.85114062 |
| 25 | leukocyte aggregation (GO:0070486) | 3.84646355 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.84306422 |
| 27 | response to host immune response (GO:0052572) | 3.84306422 |
| 28 | ribosome assembly (GO:0042255) | 3.82623011 |
| 29 | skin morphogenesis (GO:0043589) | 3.81320161 |
| 30 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.80148480 |
| 31 | proteasome assembly (GO:0043248) | 3.78250807 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.76133782 |
| 33 | mitotic nuclear envelope reassembly (GO:0007084) | 3.75045480 |
| 34 | nuclear envelope reassembly (GO:0031468) | 3.75045480 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.69582058 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.69113920 |
| 37 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.68239179 |
| 38 | microglial cell activation (GO:0001774) | 3.67341067 |
| 39 | regulation of fever generation (GO:0031620) | 3.58793963 |
| 40 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.58518767 |
| 41 | protein localization to endosome (GO:0036010) | 3.56061093 |
| 42 | positive regulation of interferon-alpha production (GO:0032727) | 3.55320148 |
| 43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.53820765 |
| 44 | mesodermal cell differentiation (GO:0048333) | 3.53008737 |
| 45 | granulocyte activation (GO:0036230) | 3.52714434 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.52221517 |
| 47 | * positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.51909609 |
| 48 | * positive regulation of mast cell degranulation (GO:0043306) | 3.51909609 |
| 49 | neutrophil activation (GO:0042119) | 3.46941215 |
| 50 | establishment of viral latency (GO:0019043) | 3.46333565 |
| 51 | regulation of heat generation (GO:0031650) | 3.46280047 |
| 52 | regulation of mononuclear cell migration (GO:0071675) | 3.45816593 |
| 53 | cellular extravasation (GO:0045123) | 3.45427728 |
| 54 | response to muramyl dipeptide (GO:0032495) | 3.44108032 |
| 55 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.42800842 |
| 56 | regulation of interferon-alpha production (GO:0032647) | 3.42542252 |
| 57 | response to host (GO:0075136) | 3.37855000 |
| 58 | response to host defenses (GO:0052200) | 3.37855000 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37855000 |
| 60 | regulation of chemokine biosynthetic process (GO:0045073) | 3.32588724 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.31794435 |
| 62 | reactive oxygen species biosynthetic process (GO:1903409) | 3.31584809 |
| 63 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.30516067 |
| 64 | cytokine secretion (GO:0050663) | 3.30371328 |
| 65 | regulation of podosome assembly (GO:0071801) | 3.26736425 |
| 66 | positive regulation of actin filament depolymerization (GO:0030836) | 3.25284523 |
| 67 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.25073873 |
| 68 | macrophage activation (GO:0042116) | 3.23748192 |
| 69 | membrane raft organization (GO:0031579) | 3.23273128 |
| 70 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.23105222 |
| 71 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.22965553 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22532866 |
| 73 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.22224436 |
| 74 | hypotonic response (GO:0006971) | 3.21545996 |
| 75 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.21533788 |
| 76 | * positive regulation of mast cell activation (GO:0033005) | 3.19715078 |
| 77 | positive regulation of interferon-beta production (GO:0032728) | 3.16534824 |
| 78 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.14583069 |
| 79 | regulation of metalloenzyme activity (GO:0048552) | 3.14290252 |
| 80 | detection of molecule of bacterial origin (GO:0032490) | 3.10542603 |
| 81 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.08127592 |
| 82 | negative regulation of interleukin-12 production (GO:0032695) | 3.07745527 |
| 83 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.04271547 |
| 84 | desmosome organization (GO:0002934) | 3.03903701 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 3.03095981 |
| 86 | nucleoside salvage (GO:0043174) | 3.02327790 |
| 87 | apoptotic cell clearance (GO:0043277) | 3.01398787 |
| 88 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.98412094 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96897330 |
| 90 | mitotic metaphase plate congression (GO:0007080) | 2.95362291 |
| 91 | superoxide anion generation (GO:0042554) | 2.94679534 |
| 92 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94427558 |
| 93 | cellular copper ion homeostasis (GO:0006878) | 2.93787285 |
| 94 | * regulation of mast cell degranulation (GO:0043304) | 2.93446401 |
| 95 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.91581574 |
| 96 | monocyte chemotaxis (GO:0002548) | 2.89716816 |
| 97 | protein hydroxylation (GO:0018126) | 2.89232487 |
| 98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88821464 |
| 99 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.88440193 |
| 100 | barbed-end actin filament capping (GO:0051016) | 2.86680641 |
| 101 | protein retention in ER lumen (GO:0006621) | 2.86306034 |
| 102 | pentose-phosphate shunt (GO:0006098) | 2.86151091 |
| 103 | cellular response to type I interferon (GO:0071357) | 2.83517926 |
| 104 | type I interferon signaling pathway (GO:0060337) | 2.83517926 |
| 105 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.83418885 |
| 106 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.82798769 |
| 107 | * positive regulation of leukocyte degranulation (GO:0043302) | 2.82776363 |
| 108 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.82629947 |
| 109 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.82629947 |
| 110 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.80880395 |
| 111 | AMP metabolic process (GO:0046033) | 2.80775455 |
| 112 | response to type I interferon (GO:0034340) | 2.80735373 |
| 113 | regulation of monocyte chemotaxis (GO:0090025) | 2.78648575 |
| 114 | * positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.77983342 |
| 115 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.77648539 |
| 116 | negative regulation of ligase activity (GO:0051352) | 2.77648539 |
| 117 | T-helper 1 type immune response (GO:0042088) | 2.76499377 |
| 118 | mitotic chromosome condensation (GO:0007076) | 2.75924269 |
| 119 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.74917413 |
| 120 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.74480830 |
| 121 | regulation of antigen processing and presentation (GO:0002577) | 2.74244327 |
| 122 | I-kappaB phosphorylation (GO:0007252) | 2.74038375 |
| 123 | * regulation of mast cell activation involved in immune response (GO:0033006) | 2.72719836 |
| 124 | * positive regulation of chemokine production (GO:0032722) | 2.72674218 |
| 125 | * positive regulation of interleukin-6 production (GO:0032755) | 2.71184031 |
| 126 | natural killer cell mediated immunity (GO:0002228) | 2.70551569 |
| 127 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.70551569 |
| 128 | metaphase plate congression (GO:0051310) | 2.70355119 |
| 129 | glucose catabolic process (GO:0006007) | 2.70162489 |
| 130 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.70111582 |
| 131 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.70102924 |
| 132 | * regulation of leukocyte degranulation (GO:0043300) | 2.67938859 |
| 133 | regulation of mitotic spindle organization (GO:0060236) | 2.67630528 |
| 134 | granulocyte chemotaxis (GO:0071621) | 2.67397505 |
| 135 | wound healing, spreading of epidermal cells (GO:0035313) | 2.67282032 |
| 136 | peptidyl-proline hydroxylation (GO:0019511) | 2.67252050 |
| 137 | leukocyte mediated cytotoxicity (GO:0001909) | 2.66448983 |
| 138 | NADPH regeneration (GO:0006740) | 2.66209945 |
| 139 | cell adhesion mediated by integrin (GO:0033627) | 2.65734630 |
| 140 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.65209828 |
| 141 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.65179366 |
| 142 | leukocyte cell-cell adhesion (GO:0007159) | 2.65151182 |
| 143 | positive regulation of p38MAPK cascade (GO:1900745) | 2.64354940 |
| 144 | neutrophil chemotaxis (GO:0030593) | 2.63801154 |
| 145 | substrate-dependent cell migration (GO:0006929) | 2.63534819 |
| 146 | mitotic sister chromatid segregation (GO:0000070) | 2.63401281 |
| 147 | ribosomal large subunit biogenesis (GO:0042273) | 2.63330603 |
| 148 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.63058702 |
| 149 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.62576061 |
| 150 | muscle cell migration (GO:0014812) | 2.61789440 |
| 151 | positive regulation of macrophage cytokine production (GO:0060907) | 2.60817024 |
| 152 | B cell mediated immunity (GO:0019724) | 2.60759679 |
| 153 | de novo protein folding (GO:0006458) | 2.60337034 |
| 154 | cell-substrate junction assembly (GO:0007044) | 2.59276612 |
| 155 | regulation of superoxide anion generation (GO:0032928) | 2.57931593 |
| 156 | regulation of spindle organization (GO:0090224) | 2.57472890 |
| 157 | protein heterotetramerization (GO:0051290) | 2.55019034 |
| 158 | negative regulation of mitochondrion organization (GO:0010823) | 2.54981140 |
| 159 | DNA unwinding involved in DNA replication (GO:0006268) | 2.54974027 |
| 160 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.53612799 |
| 161 | extracellular fibril organization (GO:0043206) | 2.53003503 |
| 162 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.52137802 |
| 163 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.51901172 |
| 164 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.51459572 |
| 165 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.51150132 |
| 166 | pyrimidine nucleoside salvage (GO:0043097) | 2.50457906 |
| 167 | pyrimidine-containing compound salvage (GO:0008655) | 2.50457906 |
| 168 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.49545531 |
| 169 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.49545531 |
| 170 | regulation of exit from mitosis (GO:0007096) | 2.49506916 |
| 171 | pinocytosis (GO:0006907) | 2.48860259 |
| 172 | protein localization to chromosome, centromeric region (GO:0071459) | 2.48706934 |
| 173 | cellular response to arsenic-containing substance (GO:0071243) | 2.48290460 |
| 174 | regulation of translational termination (GO:0006449) | 2.47030703 |
| 175 | proline biosynthetic process (GO:0006561) | 2.46510375 |
| 176 | negative regulation of anoikis (GO:2000811) | 2.45247723 |
| 177 | establishment of chromosome localization (GO:0051303) | 2.43905349 |
| 178 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.42632705 |
| 179 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.41727162 |
| 180 | de novo posttranslational protein folding (GO:0051084) | 2.41657917 |
| 181 | ventricular cardiac muscle cell development (GO:0055015) | 2.40119479 |
| 182 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.39369436 |
| 183 | type B pancreatic cell proliferation (GO:0044342) | 2.36386915 |
| 184 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.36360961 |
| 185 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.34929428 |
| 186 | hepatocyte differentiation (GO:0070365) | 2.34648493 |
| 187 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.33619710 |
| 188 | cellular protein complex localization (GO:0034629) | 2.32171721 |
| 189 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.29623801 |
| 190 | cyclooxygenase pathway (GO:0019371) | 2.27691179 |
| 191 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.26247870 |
| 192 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.24794443 |
| 193 | lipopolysaccharide metabolic process (GO:0008653) | 2.24101233 |
| 194 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.23578333 |
| 195 | protein localization to kinetochore (GO:0034501) | 2.22603936 |
| 196 | protein localization to microtubule (GO:0035372) | 2.22494546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.53666038 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.13211893 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.65115690 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.35162963 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72426086 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58032804 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.40152174 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.36334768 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.35968399 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.28044690 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.27203229 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17415356 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.00079195 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.99834702 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.90797213 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.73971387 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72092311 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.68563323 |
| 19 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.60786977 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.59320233 |
| 21 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.54913554 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.51974361 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.50210971 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47490028 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.40435564 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40431642 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29268581 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.27064154 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21138862 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.20756259 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.19735658 |
| 32 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17345787 |
| 33 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.15242793 |
| 34 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.14129794 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.12817811 |
| 36 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.12175002 |
| 37 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.10387527 |
| 38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.98496838 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.96413573 |
| 40 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.92377599 |
| 41 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90202595 |
| 42 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.86442922 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85885274 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.82359953 |
| 45 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.80710280 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80599803 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80458251 |
| 48 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79502230 |
| 49 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.76862662 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.76430305 |
| 51 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.75891355 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74293658 |
| 53 | ATF3_27146783_Chip-Seq_COLON_Human | 1.72837607 |
| 54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67419764 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.66177569 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64519579 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63961917 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63526052 |
| 59 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62631001 |
| 60 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.62126496 |
| 61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.60408317 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.59888664 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59168860 |
| 64 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58579844 |
| 65 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.57317567 |
| 66 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.55656828 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51989346 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51515399 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50838495 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50628931 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50172944 |
| 72 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50008045 |
| 73 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49617527 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49236111 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.48307706 |
| 76 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.47085460 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.45753536 |
| 78 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.45671040 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45465683 |
| 80 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.44576147 |
| 81 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.43771764 |
| 82 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.42119809 |
| 83 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.42062335 |
| 84 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.40978613 |
| 85 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.40755731 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38838889 |
| 87 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.37251518 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36606001 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36606001 |
| 90 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.36488148 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36169562 |
| 92 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34986042 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34944322 |
| 94 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34596885 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32229188 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31005267 |
| 97 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30955744 |
| 98 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30741113 |
| 99 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29516624 |
| 100 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28606771 |
| 101 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27109054 |
| 102 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26734225 |
| 103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26031037 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25336557 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23004587 |
| 106 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22599098 |
| 107 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22319207 |
| 108 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.21579441 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20980849 |
| 110 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20593199 |
| 111 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20385709 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20385709 |
| 113 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20284448 |
| 114 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19575889 |
| 115 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.19219050 |
| 116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17695451 |
| 117 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17513466 |
| 118 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16576518 |
| 119 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.16561879 |
| 120 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16386269 |
| 121 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16288405 |
| 122 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16225913 |
| 123 | MYB_26560356_Chip-Seq_TH2_Human | 1.15196930 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13730286 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13324022 |
| 126 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.12642037 |
| 127 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11874153 |
| 128 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11777475 |
| 129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11718782 |
| 130 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.10551989 |
| 131 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10055003 |
| 132 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.09821647 |
| 133 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08299773 |
| 134 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08218979 |
| 135 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07904241 |
| 136 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.05083471 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04635264 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03865512 |
| 139 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03190617 |
| 140 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02200888 |
| 141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02012713 |
| 142 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01658070 |
| 143 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.00749957 |
| 144 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00304130 |
| 145 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00011562 |
| 146 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99097272 |
| 147 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98832764 |
| 148 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98308132 |
| 149 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98095899 |
| 150 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97495210 |
| 151 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97346909 |
| 152 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96015031 |
| 153 | MAF_26560356_Chip-Seq_TH1_Human | 0.95958240 |
| 154 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95717248 |
| 155 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94162404 |
| 156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93628974 |
| 157 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93004083 |
| 158 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92499445 |
| 159 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91635492 |
| 160 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90313159 |
| 161 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87917893 |
| 162 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86674969 |
| 163 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86265137 |
| 164 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.86071787 |
| 165 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85965041 |
| 166 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.84763450 |
| 167 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.82371700 |
| 168 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.81859367 |
| 169 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.80499820 |
| 170 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80423138 |
| 171 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79341043 |
| 172 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78355862 |
| 173 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77384016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.96465539 |
| 2 | MP0003303_peritoneal_inflammation | 3.79192409 |
| 3 | * MP0002148_abnormal_hypersensitivity_rea | 3.10119830 |
| 4 | MP0009785_altered_susceptibility_to | 3.09232843 |
| 5 | MP0004272_abnormal_basement_membrane | 3.05628783 |
| 6 | MP0002419_abnormal_innate_immunity | 3.04189020 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.96773007 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.83757331 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.82839570 |
| 10 | MP0002254_reproductive_system_inflammat | 2.79559007 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.74439898 |
| 12 | MP0003724_increased_susceptibility_to | 2.60306163 |
| 13 | MP0005025_abnormal_response_to | 2.41581226 |
| 14 | MP0001533_abnormal_skeleton_physiology | 2.39225436 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.29360605 |
| 16 | MP0001790_abnormal_immune_system | 2.25387885 |
| 17 | MP0005387_immune_system_phenotype | 2.25387885 |
| 18 | MP0005623_abnormal_meninges_morphology | 2.23426770 |
| 19 | MP0003075_altered_response_to | 2.19327851 |
| 20 | MP0009764_decreased_sensitivity_to | 2.12196594 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.09614426 |
| 22 | MP0009840_abnormal_foam_cell | 2.09324775 |
| 23 | * MP0002452_abnormal_antigen_presenting | 2.08615457 |
| 24 | MP0004947_skin_inflammation | 2.03640575 |
| 25 | MP0001853_heart_inflammation | 2.03369494 |
| 26 | MP0003690_abnormal_glial_cell | 2.00990146 |
| 27 | MP0008007_abnormal_cellular_replicative | 1.99236391 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.98639265 |
| 29 | MP0004858_abnormal_nervous_system | 1.97133785 |
| 30 | * MP0000343_altered_response_to | 1.96682168 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.94395865 |
| 32 | MP0004782_abnormal_surfactant_physiolog | 1.93768132 |
| 33 | MP0005671_abnormal_response_to | 1.93358518 |
| 34 | MP0003448_altered_tumor_morphology | 1.92987589 |
| 35 | MP0005451_abnormal_body_composition | 1.91524447 |
| 36 | * MP0002723_abnormal_immune_serum | 1.88344829 |
| 37 | MP0006082_CNS_inflammation | 1.87706792 |
| 38 | MP0005501_abnormal_skin_physiology | 1.85852076 |
| 39 | MP0008932_abnormal_embryonic_tissue | 1.83742297 |
| 40 | MP0004957_abnormal_blastocyst_morpholog | 1.82615201 |
| 41 | MP0002405_respiratory_system_inflammati | 1.82514042 |
| 42 | MP0006054_spinal_hemorrhage | 1.81863944 |
| 43 | MP0003111_abnormal_nucleus_morphology | 1.77696043 |
| 44 | MP0000685_abnormal_immune_system | 1.77082027 |
| 45 | MP0001800_abnormal_humoral_immune | 1.72922785 |
| 46 | MP0000604_amyloidosis | 1.69796958 |
| 47 | MP0000858_altered_metastatic_potential | 1.68797685 |
| 48 | MP0003077_abnormal_cell_cycle | 1.68257874 |
| 49 | * MP0001819_abnormal_immune_cell | 1.67670323 |
| 50 | * MP0002420_abnormal_adaptive_immunity | 1.67143630 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.66563539 |
| 52 | MP0009278_abnormal_bone_marrow | 1.63749628 |
| 53 | * MP0001845_abnormal_inflammatory_respons | 1.62725888 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.59899961 |
| 55 | MP0004510_myositis | 1.57329719 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.55389610 |
| 57 | MP0001958_emphysema | 1.53755695 |
| 58 | MP0000358_abnormal_cell_content/ | 1.52536753 |
| 59 | MP0000762_abnormal_tongue_morphology | 1.47150307 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.46749380 |
| 61 | MP0003693_abnormal_embryo_hatching | 1.46443538 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.46270413 |
| 63 | MP0008260_abnormal_autophagy | 1.43300617 |
| 64 | MP0005390_skeleton_phenotype | 1.42791674 |
| 65 | MP0010094_abnormal_chromosome_stability | 1.41989763 |
| 66 | MP0005166_decreased_susceptibility_to | 1.40153490 |
| 67 | MP0003786_premature_aging | 1.36408493 |
| 68 | MP0003279_aneurysm | 1.35914300 |
| 69 | * MP0005164_abnormal_response_to | 1.35856622 |
| 70 | MP0005076_abnormal_cell_differentiation | 1.32857824 |
| 71 | MP0001849_ear_inflammation | 1.31406522 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.31221786 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 1.27880470 |
| 74 | MP0005310_abnormal_salivary_gland | 1.27711873 |
| 75 | MP0002796_impaired_skin_barrier | 1.27322610 |
| 76 | MP0009053_abnormal_anal_canal | 1.26773319 |
| 77 | * MP0008469_abnormal_protein_level | 1.25367083 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 1.24791262 |
| 79 | MP0005257_abnormal_intraocular_pressure | 1.24430472 |
| 80 | MP0003941_abnormal_skin_development | 1.24133371 |
| 81 | MP0000537_abnormal_urethra_morphology | 1.23608666 |
| 82 | MP0010678_abnormal_skin_adnexa | 1.22280336 |
| 83 | MP0003646_muscle_fatigue | 1.21875402 |
| 84 | MP0010368_abnormal_lymphatic_system | 1.21838967 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 1.20822241 |
| 86 | MP0003091_abnormal_cell_migration | 1.20119366 |
| 87 | MP0010771_integument_phenotype | 1.19469686 |
| 88 | MP0004233_abnormal_muscle_weight | 1.19196315 |
| 89 | MP0000579_abnormal_nail_morphology | 1.16469501 |
| 90 | MP0005621_abnormal_cell_physiology | 1.15784882 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 1.15217367 |
| 92 | MP0010030_abnormal_orbit_morphology | 1.12638238 |
| 93 | MP0003705_abnormal_hypodermis_morpholog | 1.12381989 |
| 94 | MP0000350_abnormal_cell_proliferation | 1.11408829 |
| 95 | MP0002234_abnormal_pharynx_morphology | 1.11230746 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 1.10237468 |
| 97 | MP0003136_yellow_coat_color | 1.09757408 |
| 98 | MP0003950_abnormal_plasma_membrane | 1.09429549 |
| 99 | MP0000767_abnormal_smooth_muscle | 1.08129079 |
| 100 | MP0005023_abnormal_wound_healing | 1.07759061 |
| 101 | MP0005384_cellular_phenotype | 1.04654718 |
| 102 | MP0001851_eye_inflammation | 1.04552664 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 1.03600794 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 1.02988411 |
| 105 | MP0002006_tumorigenesis | 1.02004974 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00062015 |
| 107 | MP0000467_abnormal_esophagus_morphology | 0.99448450 |
| 108 | MP0001730_embryonic_growth_arrest | 0.99114433 |
| 109 | MP0003828_pulmonary_edema | 0.98927450 |
| 110 | MP0005083_abnormal_biliary_tract | 0.98241147 |
| 111 | MP0003718_maternal_effect | 0.97684903 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.96986589 |
| 113 | MP0002933_joint_inflammation | 0.96402829 |
| 114 | MP0000716_abnormal_immune_system | 0.95604378 |
| 115 | * MP0000249_abnormal_blood_vessel | 0.93730873 |
| 116 | MP0003795_abnormal_bone_structure | 0.93420104 |
| 117 | MP0008058_abnormal_DNA_repair | 0.92559030 |
| 118 | MP0002080_prenatal_lethality | 0.92385212 |
| 119 | MP0001243_abnormal_dermal_layer | 0.92090810 |
| 120 | MP0000490_abnormal_crypts_of | 0.88112734 |
| 121 | MP0001346_abnormal_lacrimal_gland | 0.87829067 |
| 122 | MP0001915_intracranial_hemorrhage | 0.87321788 |
| 123 | MP0001542_abnormal_bone_strength | 0.86032281 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.85260140 |
| 125 | MP0000678_abnormal_parathyroid_gland | 0.84485745 |
| 126 | MP0000749_muscle_degeneration | 0.84043909 |
| 127 | MP0005397_hematopoietic_system_phenotyp | 0.83178525 |
| 128 | MP0001545_abnormal_hematopoietic_system | 0.83178525 |
| 129 | MP0002086_abnormal_extraembryonic_tissu | 0.83072976 |
| 130 | MP0005193_abnormal_anterior_eye | 0.82908129 |
| 131 | MP0008004_abnormal_stomach_pH | 0.82347397 |
| 132 | MP0003186_abnormal_redox_activity | 0.82304619 |
| 133 | MP0001879_abnormal_lymphatic_vessel | 0.81671018 |
| 134 | MP0001697_abnormal_embryo_size | 0.78589215 |
| 135 | MP0000371_diluted_coat_color | 0.76923491 |
| 136 | MP0004883_abnormal_blood_vessel | 0.76500570 |
| 137 | MP0001216_abnormal_epidermal_layer | 0.75092852 |
| 138 | MP0003011_delayed_dark_adaptation | 0.74771393 |
| 139 | MP0000613_abnormal_salivary_gland | 0.74445713 |
| 140 | MP0009384_cardiac_valve_regurgitation | 0.74435709 |
| 141 | MP0000313_abnormal_cell_death | 0.73402750 |
| 142 | MP0005275_abnormal_skin_tensile | 0.73057937 |
| 143 | MP0002398_abnormal_bone_marrow | 0.72717721 |
| 144 | MP0002098_abnormal_vibrissa_morphology | 0.72670847 |
| 145 | MP0002332_abnormal_exercise_endurance | 0.72626571 |
| 146 | MP0000750_abnormal_muscle_regeneration | 0.72120771 |
| 147 | MP0005330_cardiomyopathy | 0.71934117 |
| 148 | MP0010307_abnormal_tumor_latency | 0.70990727 |
| 149 | MP0002896_abnormal_bone_mineralization | 0.70740618 |
| 150 | MP0001191_abnormal_skin_condition | 0.70594381 |
| 151 | MP0005379_endocrine/exocrine_gland_phen | 0.70276772 |
| 152 | MP0000627_abnormal_mammary_gland | 0.70266702 |
| 153 | MP0005380_embryogenesis_phenotype | 0.70028695 |
| 154 | MP0001672_abnormal_embryogenesis/_devel | 0.70028695 |
| 155 | MP0004185_abnormal_adipocyte_glucose | 0.69739311 |
| 156 | MP0010352_gastrointestinal_tract_polyps | 0.68687835 |
| 157 | MP0003315_abnormal_perineum_morphology | 0.67726944 |
| 158 | MP0002429_abnormal_blood_cell | 0.67566377 |
| 159 | MP0003634_abnormal_glial_cell | 0.66729241 |
| 160 | MP0002877_abnormal_melanocyte_morpholog | 0.66574213 |
| 161 | MP0005197_abnormal_uvea_morphology | 0.65892536 |
| 162 | MP0001727_abnormal_embryo_implantation | 0.65625028 |
| 163 | MP0002060_abnormal_skin_morphology | 0.65615187 |
| 164 | MP0005165_increased_susceptibility_to | 0.65481359 |
| 165 | MP0000383_abnormal_hair_follicle | 0.64842350 |
| 166 | MP0010386_abnormal_urinary_bladder | 0.64452865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.73436767 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.59988237 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.82659539 |
| 4 | Premature rupture of membranes (HP:0001788) | 4.68815091 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.66704875 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.51579420 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 4.39562071 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.37535049 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.13901474 |
| 10 | Short nail (HP:0001799) | 3.99630288 |
| 11 | Stomatitis (HP:0010280) | 3.93952677 |
| 12 | Orchitis (HP:0100796) | 3.71809269 |
| 13 | Interstitial pulmonary disease (HP:0006530) | 3.69527188 |
| 14 | Entropion (HP:0000621) | 3.63131509 |
| 15 | Tetraparesis (HP:0002273) | 3.60129221 |
| 16 | Gingivitis (HP:0000230) | 3.57044593 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54316738 |
| 18 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.49470370 |
| 19 | Myositis (HP:0100614) | 3.42833570 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.41596463 |
| 21 | Optic neuritis (HP:0100653) | 3.41596463 |
| 22 | Increased mean platelet volume (HP:0011877) | 3.38311430 |
| 23 | Onycholysis (HP:0001806) | 3.37796546 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.36617616 |
| 25 | Atrophic scars (HP:0001075) | 3.36306924 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.28201945 |
| 27 | Thick nail (HP:0001805) | 3.07513765 |
| 28 | Dysostosis multiplex (HP:0000943) | 3.07358187 |
| 29 | Menorrhagia (HP:0000132) | 3.06837604 |
| 30 | Upper limb muscle weakness (HP:0003484) | 3.02672353 |
| 31 | Urticaria (HP:0001025) | 3.00799610 |
| 32 | Pulmonary infiltrates (HP:0002113) | 2.95289783 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.90071626 |
| 34 | Axonal loss (HP:0003447) | 2.89364961 |
| 35 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.86375302 |
| 36 | Abnormal platelet volume (HP:0011876) | 2.82788914 |
| 37 | Basal ganglia calcification (HP:0002135) | 2.73742629 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73001921 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73001921 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73001921 |
| 41 | Vertebral compression fractures (HP:0002953) | 2.72983968 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.71881257 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71881257 |
| 44 | Fragile nails (HP:0001808) | 2.71530896 |
| 45 | Pustule (HP:0200039) | 2.71164289 |
| 46 | Trismus (HP:0000211) | 2.70793860 |
| 47 | Diplopia (HP:0000651) | 2.66946937 |
| 48 | Abnormality of binocular vision (HP:0011514) | 2.66946937 |
| 49 | Myocardial infarction (HP:0001658) | 2.66032042 |
| 50 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.65776091 |
| 51 | Aplasia of the phalanges of the hand (HP:0009802) | 2.65776091 |
| 52 | Aplasia involving bones of the extremities (HP:0009825) | 2.65776091 |
| 53 | Abnormality of glycolysis (HP:0004366) | 2.65229040 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63579869 |
| 55 | Obstructive lung disease (HP:0006536) | 2.63579869 |
| 56 | Recurrent skin infections (HP:0001581) | 2.61938808 |
| 57 | Poikiloderma (HP:0001029) | 2.59703731 |
| 58 | Fragile skin (HP:0001030) | 2.57949838 |
| 59 | Cholecystitis (HP:0001082) | 2.57517059 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.57517059 |
| 61 | Chronic otitis media (HP:0000389) | 2.56442285 |
| 62 | Nail dystrophy (HP:0008404) | 2.55880637 |
| 63 | Vasculitis (HP:0002633) | 2.55854378 |
| 64 | Male infertility (HP:0003251) | 2.55791308 |
| 65 | Periodontitis (HP:0000704) | 2.54279198 |
| 66 | Milia (HP:0001056) | 2.53428755 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.52854991 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51655015 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51655015 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51655015 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.48462331 |
| 72 | Hypokinesia (HP:0002375) | 2.44596115 |
| 73 | Rough bone trabeculation (HP:0100670) | 2.43554592 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.43054886 |
| 75 | Premature loss of primary teeth (HP:0006323) | 2.40717029 |
| 76 | Abnormality of the umbilical cord (HP:0010881) | 2.39808892 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.39154618 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39154618 |
| 79 | Loss of speech (HP:0002371) | 2.38364643 |
| 80 | Natal tooth (HP:0000695) | 2.37817540 |
| 81 | Alopecia of scalp (HP:0002293) | 2.35032837 |
| 82 | Sparse eyelashes (HP:0000653) | 2.31764789 |
| 83 | Recurrent fungal infections (HP:0002841) | 2.27691073 |
| 84 | Protrusio acetabuli (HP:0003179) | 2.23192365 |
| 85 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.22244055 |
| 86 | Arterial tortuosity (HP:0005116) | 2.21712684 |
| 87 | Syringomyelia (HP:0003396) | 2.21707751 |
| 88 | Spinal cord lesions (HP:0100561) | 2.21707751 |
| 89 | Mitral stenosis (HP:0001718) | 2.18683161 |
| 90 | Pathologic fracture (HP:0002756) | 2.16984270 |
| 91 | Achilles tendon contracture (HP:0001771) | 2.16497868 |
| 92 | Selective tooth agenesis (HP:0001592) | 2.15220517 |
| 93 | Prostate neoplasm (HP:0100787) | 2.12272633 |
| 94 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.10931508 |
| 95 | Disinhibition (HP:0000734) | 2.10856001 |
| 96 | Leukocytosis (HP:0001974) | 2.10819764 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 2.09597722 |
| 98 | Progressive visual loss (HP:0000529) | 2.09457691 |
| 99 | Abnormal auditory evoked potentials (HP:0006958) | 2.09032943 |
| 100 | Microglossia (HP:0000171) | 2.08400695 |
| 101 | Cellulitis (HP:0100658) | 2.06393712 |
| 102 | Increased IgM level (HP:0003496) | 2.06246718 |
| 103 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.05040805 |
| 104 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.05040805 |
| 105 | Single umbilical artery (HP:0001195) | 2.05040805 |
| 106 | Xerostomia (HP:0000217) | 2.01337147 |
| 107 | Peritonitis (HP:0002586) | 2.01151928 |
| 108 | Distal lower limb amyotrophy (HP:0008944) | 1.99234849 |
| 109 | Albinism (HP:0001022) | 1.97349653 |
| 110 | Arterial thrombosis (HP:0004420) | 1.96895598 |
| 111 | Spondylolisthesis (HP:0003302) | 1.96297426 |
| 112 | Abnormality of placental membranes (HP:0011409) | 1.95418696 |
| 113 | Amniotic constriction ring (HP:0009775) | 1.95418696 |
| 114 | Multiple lipomas (HP:0001012) | 1.94829839 |
| 115 | Nuclear cataract (HP:0100018) | 1.93977739 |
| 116 | Glucose intolerance (HP:0000833) | 1.92933619 |
| 117 | Bone pain (HP:0002653) | 1.92745446 |
| 118 | Aortic dissection (HP:0002647) | 1.92690878 |
| 119 | Vertebral hypoplasia (HP:0008417) | 1.92378205 |
| 120 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.92378205 |
| 121 | Clumsiness (HP:0002312) | 1.92175396 |
| 122 | Deviation of the thumb (HP:0009603) | 1.91313151 |
| 123 | Purpura (HP:0000979) | 1.90937590 |
| 124 | Elbow flexion contracture (HP:0002987) | 1.90823737 |
| 125 | Cardiovascular calcification (HP:0011915) | 1.90070031 |
| 126 | Impaired platelet aggregation (HP:0003540) | 1.89721725 |
| 127 | Abnormal platelet function (HP:0011869) | 1.89721725 |
| 128 | Cervical subluxation (HP:0003308) | 1.89022226 |
| 129 | Vascular tortuosity (HP:0004948) | 1.88712434 |
| 130 | Increased IgE level (HP:0003212) | 1.88565294 |
| 131 | Squamous cell carcinoma (HP:0002860) | 1.88237664 |
| 132 | Hydroxyprolinuria (HP:0003080) | 1.88134254 |
| 133 | Abnormality of proline metabolism (HP:0010907) | 1.88134254 |
| 134 | Amyloidosis (HP:0011034) | 1.87911152 |
| 135 | Generalized amyotrophy (HP:0003700) | 1.87281601 |
| 136 | Abnormality of oral frenula (HP:0000190) | 1.86297311 |
| 137 | Tongue fasciculations (HP:0001308) | 1.85519075 |
| 138 | Neoplasm of head and neck (HP:0012288) | 1.85444089 |
| 139 | Esophageal neoplasm (HP:0100751) | 1.85444089 |
| 140 | Hypergammaglobulinemia (HP:0010702) | 1.85197844 |
| 141 | Palmoplantar hyperkeratosis (HP:0000972) | 1.84985909 |
| 142 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84572635 |
| 143 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.84338620 |
| 144 | Adactyly (HP:0009776) | 1.83489062 |
| 145 | Orthostatic hypotension (HP:0001278) | 1.83351581 |
| 146 | Hepatosplenomegaly (HP:0001433) | 1.83129290 |
| 147 | Hypoplastic pelvis (HP:0008839) | 1.82911166 |
| 148 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.82172647 |
| 149 | Plantar hyperkeratosis (HP:0007556) | 1.81898983 |
| 150 | Fasciculations (HP:0002380) | 1.81787685 |
| 151 | Type I transferrin isoform profile (HP:0003642) | 1.81678131 |
| 152 | Anhidrosis (HP:0000970) | 1.80953643 |
| 153 | Abnormal trabecular bone morphology (HP:0100671) | 1.80292236 |
| 154 | Distal upper limb amyotrophy (HP:0007149) | 1.79910395 |
| 155 | Upper limb amyotrophy (HP:0009129) | 1.79910395 |
| 156 | Limb-girdle muscle atrophy (HP:0003797) | 1.79551686 |
| 157 | Pterygium (HP:0001059) | 1.77056985 |
| 158 | Petechiae (HP:0000967) | 1.76994023 |
| 159 | Recurrent corneal erosions (HP:0000495) | 1.76822238 |
| 160 | Adrenal hypoplasia (HP:0000835) | 1.76679926 |
| 161 | Absent frontal sinuses (HP:0002688) | 1.76165589 |
| 162 | Craniofacial hyperostosis (HP:0004493) | 1.75265368 |
| 163 | Progressive hearing impairment (HP:0001730) | 1.75183765 |
| 164 | Vascular calcification (HP:0004934) | 1.75119055 |
| 165 | Abnormality of the frontal sinuses (HP:0002687) | 1.74493657 |
| 166 | Progressive neurologic deterioration (HP:0002344) | 1.74456937 |
| 167 | Broad face (HP:0000283) | 1.74368117 |
| 168 | Osteomyelitis (HP:0002754) | 1.73821568 |
| 169 | Nasal polyposis (HP:0100582) | 1.73678281 |
| 170 | Abnormality of the anterior horn cell (HP:0006802) | 1.72894438 |
| 171 | Degeneration of anterior horn cells (HP:0002398) | 1.72894438 |
| 172 | Shoulder girdle muscle weakness (HP:0003547) | 1.72754768 |
| 173 | Sepsis (HP:0100806) | 1.71790128 |
| 174 | Hematochezia (HP:0002573) | 1.71607138 |
| 175 | Palmar hyperkeratosis (HP:0010765) | 1.71522277 |
| 176 | Episodic fever (HP:0001954) | 1.71132316 |
| 177 | Ankyloglossia (HP:0010296) | 1.70805534 |
| 178 | Reduced antithrombin III activity (HP:0001976) | 1.70689426 |
| 179 | Prolonged neonatal jaundice (HP:0006579) | 1.69987461 |
| 180 | Breast hypoplasia (HP:0003187) | 1.69617448 |
| 181 | Distal lower limb muscle weakness (HP:0009053) | 1.69387124 |
| 182 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.69160181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.76084672 |
| 2 | EPHA2 | 4.73924467 |
| 3 | RIPK4 | 4.35280027 |
| 4 | BUB1 | 3.27755590 |
| 5 | TBK1 | 3.22626635 |
| 6 | IRAK3 | 3.20530437 |
| 7 | TYK2 | 2.55627572 |
| 8 | PIM2 | 2.52523934 |
| 9 | BLK | 2.51119660 |
| 10 | EIF2AK1 | 2.41991037 |
| 11 | ERN1 | 2.36550567 |
| 12 | PBK | 2.30488229 |
| 13 | TAOK2 | 2.19783003 |
| 14 | IKBKE | 2.08379339 |
| 15 | PAK4 | 2.05152472 |
| 16 | TRIB3 | 2.01870606 |
| 17 | TESK2 | 1.98176731 |
| 18 | IKBKB | 1.97468452 |
| 19 | MAP3K13 | 1.92027600 |
| 20 | LIMK1 | 1.90750195 |
| 21 | IRAK4 | 1.86203743 |
| 22 | NEK1 | 1.85390502 |
| 23 | EIF2AK3 | 1.83643327 |
| 24 | CSK | 1.82273078 |
| 25 | NME2 | 1.82121025 |
| 26 | JAK3 | 1.76869914 |
| 27 | FGR | 1.71532768 |
| 28 | VRK2 | 1.68683520 |
| 29 | STK10 | 1.62003613 |
| 30 | MST1R | 1.57702632 |
| 31 | MST4 | 1.56619374 |
| 32 | EPHB1 | 1.55178302 |
| 33 | CHUK | 1.54550838 |
| 34 | CDK8 | 1.52932647 |
| 35 | BMX | 1.48907436 |
| 36 | LRRK2 | 1.46040948 |
| 37 | STK24 | 1.39883827 |
| 38 | ARAF | 1.39301307 |
| 39 | KIT | 1.34592259 |
| 40 | MAP4K1 | 1.30339583 |
| 41 | TXK | 1.30249318 |
| 42 | EPHB2 | 1.29535351 |
| 43 | MAP3K3 | 1.29198489 |
| 44 | MAP3K12 | 1.20877600 |
| 45 | SRPK1 | 1.17918363 |
| 46 | MATK | 1.17159259 |
| 47 | TTK | 1.17096536 |
| 48 | JAK1 | 1.16897520 |
| 49 | SCYL2 | 1.16845555 |
| 50 | ZAP70 | 1.13301879 |
| 51 | MOS | 1.12509916 |
| 52 | PTK6 | 1.09464590 |
| 53 | TSSK6 | 1.06093738 |
| 54 | EPHA3 | 1.03806657 |
| 55 | MYLK | 1.03105665 |
| 56 | TRPM7 | 1.00614517 |
| 57 | LYN | 1.00494060 |
| 58 | LATS2 | 1.00147455 |
| 59 | ILK | 0.99324418 |
| 60 | MARK3 | 0.97315624 |
| 61 | MAP3K5 | 0.95978638 |
| 62 | HCK | 0.95628654 |
| 63 | MAP3K1 | 0.93885277 |
| 64 | TRIM28 | 0.93206381 |
| 65 | PIM1 | 0.88204062 |
| 66 | BRSK1 | 0.88144526 |
| 67 | ABL2 | 0.85271936 |
| 68 | WEE1 | 0.84495098 |
| 69 | TGFBR2 | 0.83852960 |
| 70 | STK3 | 0.82573942 |
| 71 | RPS6KA4 | 0.82382248 |
| 72 | TAOK1 | 0.82333116 |
| 73 | BRAF | 0.80941478 |
| 74 | JAK2 | 0.80117043 |
| 75 | SIK1 | 0.79943240 |
| 76 | FLT3 | 0.79293751 |
| 77 | ERBB3 | 0.78891258 |
| 78 | ICK | 0.77199515 |
| 79 | FGFR3 | 0.75604965 |
| 80 | LCK | 0.74607043 |
| 81 | TAOK3 | 0.73710547 |
| 82 | FES | 0.73243190 |
| 83 | RIPK1 | 0.73109658 |
| 84 | ABL1 | 0.72073505 |
| 85 | ERBB4 | 0.71143205 |
| 86 | PAK1 | 0.70791385 |
| 87 | CLK1 | 0.70418001 |
| 88 | AURKA | 0.70001436 |
| 89 | PTK2B | 0.69663107 |
| 90 | MET | 0.69480012 |
| 91 | PLK1 | 0.69246872 |
| 92 | YES1 | 0.68291638 |
| 93 | ADRBK1 | 0.67073443 |
| 94 | PDGFRA | 0.66952956 |
| 95 | DAPK1 | 0.66601586 |
| 96 | SIK3 | 0.66402034 |
| 97 | PRKCQ | 0.66310799 |
| 98 | SYK | 0.65495249 |
| 99 | BMPR2 | 0.65207864 |
| 100 | NEK2 | 0.64512045 |
| 101 | PAK2 | 0.64487860 |
| 102 | PLK3 | 0.63416073 |
| 103 | PRKG2 | 0.63192747 |
| 104 | BTK | 0.63014104 |
| 105 | CCNB1 | 0.62919524 |
| 106 | DDR2 | 0.61453637 |
| 107 | STK16 | 0.60901698 |
| 108 | EGFR | 0.59868960 |
| 109 | RAF1 | 0.59746263 |
| 110 | STK4 | 0.59095755 |
| 111 | LMTK2 | 0.58176576 |
| 112 | KSR2 | 0.57613239 |
| 113 | BRSK2 | 0.57406472 |
| 114 | LATS1 | 0.57177661 |
| 115 | PRKCD | 0.56714173 |
| 116 | MUSK | 0.56190138 |
| 117 | PIK3CG | 0.55491408 |
| 118 | SMG1 | 0.55009471 |
| 119 | AURKB | 0.54282299 |
| 120 | MAP4K2 | 0.53390340 |
| 121 | MAP3K11 | 0.52859519 |
| 122 | MAP2K3 | 0.52401807 |
| 123 | PDGFRB | 0.51419779 |
| 124 | NTRK1 | 0.50900765 |
| 125 | ADRBK2 | 0.50610903 |
| 126 | CHEK2 | 0.49979577 |
| 127 | PRKCI | 0.48217413 |
| 128 | EIF2AK2 | 0.47543602 |
| 129 | NME1 | 0.47245505 |
| 130 | ROCK2 | 0.47171007 |
| 131 | CAMK2G | 0.47021853 |
| 132 | TTN | 0.46974005 |
| 133 | CDK7 | 0.46498566 |
| 134 | MAP3K2 | 0.46239201 |
| 135 | MAPKAPK2 | 0.46177882 |
| 136 | MAP3K8 | 0.43436900 |
| 137 | HIPK2 | 0.41509077 |
| 138 | MELK | 0.40892001 |
| 139 | FYN | 0.39844141 |
| 140 | TESK1 | 0.39346980 |
| 141 | IGF1R | 0.38484715 |
| 142 | PTK2 | 0.37433475 |
| 143 | NEK9 | 0.37338756 |
| 144 | GRK7 | 0.37311501 |
| 145 | FGFR1 | 0.36822337 |
| 146 | MAP3K9 | 0.36549517 |
| 147 | TEC | 0.35922814 |
| 148 | MAPK4 | 0.35350566 |
| 149 | DAPK3 | 0.34776091 |
| 150 | PRKCE | 0.34287192 |
| 151 | INSR | 0.33599488 |
| 152 | SRC | 0.33215155 |
| 153 | CDK9 | 0.31887707 |
| 154 | PAK6 | 0.31850055 |
| 155 | CDK14 | 0.30350099 |
| 156 | PLK2 | 0.30168481 |
| 157 | KSR1 | 0.29396628 |
| 158 | CAMK2D | 0.28167662 |
| 159 | MAP3K6 | 0.26280520 |
| 160 | IRAK2 | 0.26235350 |
| 161 | VRK1 | 0.25304313 |
| 162 | CSNK1A1L | 0.23020343 |
| 163 | STK38 | 0.22969121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.47451264 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.09906248 |
| 3 | Legionellosis_Homo sapiens_hsa05134 | 2.93816668 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.87773905 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.78350929 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61959837 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.44356363 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44163094 |
| 9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.28513147 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.26113964 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23894662 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21948312 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.21790330 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 2.21530640 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18956520 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.17408531 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.11157766 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.10611993 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07420805 |
| 20 | Asthma_Homo sapiens_hsa05310 | 2.06396471 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.00157825 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.00068468 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.97558055 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.94181687 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.91536770 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.90675495 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.85952624 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.85353800 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.83167966 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.78425233 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74224815 |
| 32 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.71255319 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69619575 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.68563003 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.67110223 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67020234 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.65417360 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.64728296 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.64112621 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62667483 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.55398468 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51830930 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50887973 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.50095949 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48899461 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.48817647 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47729823 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.46857663 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.46659244 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.45010198 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42324949 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42246819 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.40843748 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.36403554 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32191302 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31972166 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30892317 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30831486 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24851340 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23594691 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22376576 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22186254 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 1.21396692 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20348929 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 1.19741485 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 1.18960470 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 1.17492536 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16521535 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15124888 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13843428 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13373749 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12840607 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12680957 |
| 74 | RNA transport_Homo sapiens_hsa03013 | 1.11440875 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09676547 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06327781 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04822644 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 1.02024514 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99833900 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97925349 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.97258921 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96836444 |
| 83 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96520699 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96469775 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94072204 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92903305 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91331208 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.87426180 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.87390993 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.86846254 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81563985 |
| 92 | Spliceosome_Homo sapiens_hsa03040 | 0.80671013 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.80297917 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78989517 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78272232 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78236330 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78141343 |
| 98 | Ribosome_Homo sapiens_hsa03010 | 0.76682188 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74888861 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74333381 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74160799 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73603123 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73508696 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70551380 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69624509 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69470994 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68008279 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67166198 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66258835 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66227908 |
| 111 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66226246 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66067280 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64606799 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.64094171 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63426108 |
| 116 | Basal transcription factors_Homo sapiens_hsa03022 | 0.62689100 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62560135 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62490660 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60476976 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59841294 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59679454 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57624865 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.55967887 |
| 124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54748038 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54494410 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54305974 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53790151 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53606128 |
| 129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51014695 |
| 130 | Protein export_Homo sapiens_hsa03060 | 0.50531880 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50526698 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49423814 |
| 133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48755299 |
| 134 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47198347 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45295902 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44179531 |
| 137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44156328 |
| 138 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43461238 |
| 139 | Adherens junction_Homo sapiens_hsa04520 | 0.43403701 |
| 140 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43265034 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41160352 |
| 142 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39809685 |
| 143 | Focal adhesion_Homo sapiens_hsa04510 | 0.38562981 |
| 144 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38499240 |
| 145 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36121154 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35803532 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35170647 |
| 148 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35161545 |
| 149 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34884381 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34780823 |
| 151 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33017294 |
| 152 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32052757 |
| 153 | Prostate cancer_Homo sapiens_hsa05215 | 0.31991790 |
| 154 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31888566 |
| 155 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31322180 |
| 156 | Endocytosis_Homo sapiens_hsa04144 | 0.31051248 |
| 157 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31037744 |
| 158 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28619163 |
| 159 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27841301 |
| 160 | Bladder cancer_Homo sapiens_hsa05219 | 0.27791467 |
| 161 | Insulin resistance_Homo sapiens_hsa04931 | 0.26754838 |
| 162 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.25560882 |

